Publications

Prevalence of non-communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta-analysis.

Hamada, Y; Quartagno, M; Malik, F; Ntshamane, K; Tisler, A; Gaikwad, S; Acuna-Villaorduna, C; Bhavani, PK; Alisjahbana, B; Ronacher, K; Apriani, L; Becerra, M; Chu, AL; Creswell, J; Diaz, G; Ferro, BE; Galea, JT; Grandjean, L; Grewal, HM S; Gupta, A; Jones-López, EC; Kleynhans, L; Lecca, L; MacPherson, P; Murray, M; ... Rangaka, MX.

2024

Tropical medicine & international health : TM & IH, (2024).29 9 10.1111/tmi.14038.

The potential impact of new TB vaccines on the burden of TB in people living with HIV in South Africa.

SUMNER, T; CLARK, RA; PRYS-JONES, TO; Bakker, R; Churchyard, G; WHITE, RG;

2024

AIDS (2024). 10.1097/QAD.0000000000004038.

The Effect of HIV on the Association of Hyperglycaemia and Active Tuberculosis in Zambia, a Case-Control Study.

Bailey, SL; FLOYD, S; Cheeba-Lengwe, M; Maluzi, K; Chiwele-Kangololo, K; Kaluba-Milimo, D; Amofa-Sekyi, M; Yudkin, JS; Godfrey-Faussett, P; AYLES, H;

2024

Journal of epidemiology and global health, (2024).14 3 10.1007/s44197-024-00236-2.

Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial.

Telisinghe, L; FLOYD, S; MACLEOD, D; SCHAAP, A; Dunbar, R; Bwalya, J; Bell-Mandla, N; Piwowar-Manning, E; Donnell, D; Shaunaube, K; Bock, P; Fidler, S; HAYES, RJ; AYLES, HM; HPTN 071 (PopART) study team,;

2024

PLoS medicine, (2024).21 5 10.1371/journal.pmed.1004393.

The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial.

Nassuuna, J; ZIRIMENYA, L; NKURUNUNGI, G; Natukunda, A; Zziwa, C; Ninsiima, C; Apule, B; Onen, C; Amongi, S; Serubanja, J; Tumwesige, P; Nsubuga, D; Amongin, R; Van Dam, GJ; Corstjens, PL A M; Kayiwa, J; Kabagenyi, J; Cose, S; WAJJA, A; KALEEBU, P; WEBB, EL; ELLIOTT, AM; POPVAC trial team,;

2024

The Lancet Global health, (2024).12 11 10.1016/S2214-109X(24)00282-1.

Estimating the Potential Public Health Value of BCG Revaccination.

CLARK, RA; SUMNER, T; Weerasuriya, CK; Bakker, R; Scriba, TJ; WHITE, RG;

2024

The Journal of infectious diseases, (2024).230 1 10.1093/infdis/jiae089.

Estimating the potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study.

CLARK, RA; Portnoy, A; Weerasuriya, CK; SUMNER, T; Bakker, R; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2024

The Lancet regional health - Southeast Asia (2024). 10.1016/j.lansea.2024.100424.

An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates.

PHELAN, J; Van den Heede, K; Masyn, S; Verbeeck, R; Lamprecht, DA; KOUL, A; WALL, RJ;

2024

Scientific reports, (2024).14 1 10.1038/s41598-024-75818-y.

Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to <i>M. tuberculosis</i> infection.

Nieuwenhuizen, NE; Nouailles, G; SUTHERLAND, JS; Zyla, J; Pasternack, AH; Heyckendorf, J; Frye, BC; Höhne, K; Zedler, U; Bandermann, S; Abu Abed, U; Brinkmann, V; Gutbier, B; Witzenrath, M; Suttorp, N; Zissel, G; Lange, C; Ritvos, O; Kaufmann, SH E; CAPNETZ Study group,; DZIF TB study group,;

2024

mBio, (2024).15 3 10.1128/mbio.03408-23.

Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach.

CRyPTIC Consortium,;

2024

Nature communications, (2024).15 1 10.1038/s41467-023-44325-5.